2 ms·
> Everyone knows we need a systemic solution, and everyone knows what that solution will eventually have to be: financial compensation for kidney donors. Anoth
by manmal 3y ago
> Everyone knows we need a systemic solution, and everyone knows what that solution will eventually have to be: financial compensation for kidney donors.
Another solution would be to tackle type 2 diabetes, since a big amount of kidney failures is caused by that. Apparently, 1/3 of Americans are at risk: https://www.health.com/cardiovascular-kidney-metabolic-syndrome-8356537 https://www.health.com/cardiovascular-kidney-metabolic-syndr...
Having worked for a few years in the diabetes space, I‘ve been hearing that cheaper CGMs are coming from the big players, apparently for <= $1 a day. This will allow people with diabetes to keep their time in the ideal BG range longer, reducing risk for kidney disease _significantly_.
- Metacelsus 3y agoOr, human-compatible kidneys grown in bioengineered pigs. GLP1 drugs are also very promising for reducing the rate of kidney disease.
- refurb 3y agoThe GLP-1 drugs should have a big impact for type II diabetes. Interestingly Fresenius, a massive dialysis provider, has taken a beating in terms of stock price with the GLP-1 data. That said, diabetes is a long-term disease and it's going to take a decade or two to see a measurable difference.